Figure 3.
Comparison of immune reconstitution. Reconstitution of DL1 (5 mg twice daily) vs DL2 (10 mg twice daily) on days 21, 35, and 100 post-HCT for CD3+ T cells (A), CD3+ T cells (B), CD8+ T cells (C), Foxp3+ Tregs (D), CD27+ B cells (E), and CD56+ NK cells (F).

Comparison of immune reconstitution. Reconstitution of DL1 (5 mg twice daily) vs DL2 (10 mg twice daily) on days 21, 35, and 100 post-HCT for CD3+ T cells (A), CD3+ T cells (B), CD8+ T cells (C), Foxp3+ Tregs (D), CD27+ B cells (E), and CD56+ NK cells (F).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal